Vanda Pharmaceuticals buy Cantor Fitzgerald
Start price
30.10.25
/
50%
€3.82
Target price
30.10.26
€9.47
Performance (%)
47.91%
Price
11.12.25
€5.65
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals has seen massive gains of 47.91%. This prediction currently runs until 30.10.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vanda Pharmaceuticals | 26.116% | 26.116% |
| iShares Core DAX® | 2.018% | 0.724% |
| iShares Nasdaq 100 | -0.476% | -0.744% |
| iShares Nikkei 225® | -0.675% | -2.884% |
| iShares S&P 500 | -0.163% | -0.442% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals (NASDAQ:VNDA) had its price target lowered by analysts at Cantor Fitzgerald from $13.00 to $11.00. They now have an "overweight" rating on the stock.
Ratings data for VNDA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€3.56
14.05.25
14.05.25
€11.62
14.05.26
14.05.26
58.71%
11.12.25
11.12.25
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€5.25
01.08.24
01.08.24
€12.05
01.08.25
01.08.25
-31.81%
02.08.25
02.08.25

